Year: 2015

The SEC filed another action centered on a restatement resulting from improper accounting and internal controls. In this instance the firm lacked procedures for dealing with related party transactions despite contrary disclosures and failed to properly value its most significant …

SEC Files Settled Action Tied To Restatement Read More »

Tagged with: , , , , ,

FCPA procedures, internal controls and travel, entertainment and gifts were at the center of the SEC’s latest FCPA action. The action names as a Respondent Bristol-Myers Squibb Company and focuses on its efforts to sell pharmaceuticals in China. In the …

SEC, Bristol-Myers Settle FCPA Charges Read More »

Tagged with: , ,